Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study.
Journal
Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835
Informations de publication
Date de publication:
11 Sep 2024
11 Sep 2024
Historique:
received:
19
12
2023
accepted:
04
09
2024
revised:
02
09
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
11
9
2024
Statut:
aheadofprint
Résumé
We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 years or older, who were interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1, 2001-2002; Wave 2, 2004-2005). The primary analyses were limited to 32,671 respondents (13,751 male (47.9% weighted); mean age of 45 years (SD = 0.18)) who were interviewed in both waves. We used multiple regression and propensity score matching (PSM) to estimate the strength of independent associations between nicotine dependence related to the use of tobacco products at Wave 1 and incident psychiatric disorders at Wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). All analyses adjusted for multiple potential confounders, including childhood (family history of substance use disorders, parental loss, vulnerable family environment), early-adolescence (self-esteem, social deviance, conduct disorder), late-adolescence (education, personality and psychiatric disorders), adulthood (divorce, stressful life events, social deviance, quality of life, history of alcohol or other substance use disorder), and sociodemographic factors. Multiple regression analysis and PSM converged in indicating that nicotine dependence was associated with significantly increased incidence of any psychiatric disorder (OR = 1.39(95%CI:1.20;1.60)), including substance use disorders (OR = 1.91(95%CI:1.47;2.47)), and anxiety disorders (OR = 1.31(95%CI:1.06;1.62)). Population Attributable Risk Proportions were substantial, ranging from 12.5%(95%CI:8.10;17.0) for any psychiatric disorder to 33.3%(95%CI:18.7;48.0) for any other drug use disorder. Supplementary analyses also indicated significant associations between nicotine dependence and persistence of psychiatric and substance use disorders among patients having a disorder at Wave 1. In the general adult population, nicotine dependence is associated with an increased likelihood for several psychiatric and substance use disorders. Given its high prevalence, these findings have important public health implications.
Identifiants
pubmed: 39261672
doi: 10.1038/s41380-024-02748-6
pii: 10.1038/s41380-024-02748-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking—50 years of progress: a report of the surgeon general. US: Centers for Disease Control and Prevention; 2014.
Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults—United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71:397–405.
pubmed: 35298455
pmcid: 8942309
doi: 10.15585/mmwr.mm7111a1
Grant BF, Shmulewitz D, Compton WM. Nicotine use and DSM-IV nicotine dependence in the United States, 2001–2002 and 2012–2013. Am J Psychiatry. 2020;177:1082–90.
pubmed: 32791895
doi: 10.1176/appi.ajp.2020.19090900
Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107.
pubmed: 15520358
doi: 10.1001/archpsyc.61.11.1107
Dierker L, Donny E. The role of psychiatric disorders in the relationship between cigarette smoking and DSM-IV nicotine dependence among young adults. Nicotine Tob Res. 2008;10:439–46.
pubmed: 18324562
doi: 10.1080/14622200801901898
Cuijpers P, Smit F, Ten Have M, De Graaf R. Smoking is associated with first-ever incidence of mental disorders: a prospective population-based study. Addiction. 2007;102:1303–1309.
pubmed: 17624980
doi: 10.1111/j.1360-0443.2007.01885.x
Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23:e147–e153.
pubmed: 24727731
doi: 10.1136/tobaccocontrol-2013-051466
Zvolensky MJ, Jenkins EF, Johnson KA, Goodwin RD. Personality disorders and cigarette smoking among adults in the United States. J Psychiatr Res. 2011;45:835–41.
pubmed: 21168156
doi: 10.1016/j.jpsychires.2010.11.009
García-Rodríguez O, Blanco C, Wall MM, Wang S, Jin CJ, Kendler KS. Toward a comprehensive developmental model of smoking initiation and nicotine dependence. Drug Alcohol Depend. 2014;144:160–9.
pubmed: 25262528
pmcid: 4253146
doi: 10.1016/j.drugalcdep.2014.09.002
Fluharty M, Taylor AE, Grabski M, Munafò MR. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2017;19:3–13.
pubmed: 27199385
doi: 10.1093/ntr/ntw140
Hoertel N, Blanco C, Oquendo MA, Wall MM, Olfson M, Falissard B, et al. A comprehensive model of predictors of persistence and recurrence in adults with major depression: results from a national 3-year prospective study. J Psychiatr Res. 2017;95:19–27.
pubmed: 28759845
pmcid: 5653405
doi: 10.1016/j.jpsychires.2017.07.022
Franco S, Olfson M, Wall MM, Wang S, Hoertel N, Blanco C. Shared and specific associations of substance use disorders on adverse outcomes: a national prospective study. Drug Alcohol Depend. 2019;201:212–9.
pubmed: 31252355
doi: 10.1016/j.drugalcdep.2019.03.003
Martínez-Ortega JM, Goldstein BI, Gutiérrez-Rojas L, Sala R, Wang S, Blanco C. Temporal sequencing of nicotine dependence and bipolar disorder in the national epidemiologic survey on alcohol and related conditions (NESARC). J Psychiatr Res. 2013;47:858–64.
pubmed: 23582710
pmcid: 3674324
doi: 10.1016/j.jpsychires.2013.03.012
Taylor G, Girling A, McNeill A, Aveyard P. Does smoking cessation result in improved mental health? A comparison of regression modelling and propensity score matching. BMJ Open. 2015;5:e008774.
pubmed: 26490099
pmcid: 4620166
doi: 10.1136/bmjopen-2015-008774
De Boer N, Vermeulen J, Lin B, Van Os J, Ten Have M, De Graaf R, et al. Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study. Psychol Med. 2023;53:1409–17.
pubmed: 35023464
doi: 10.1017/S0033291721002968
Blanco C, Wall MM, Hoertel N, Krueger RF, Liu S-M, Grant BF, et al. Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study. Mol Psychiatry. 2021;26:907–16.
pubmed: 31350462
doi: 10.1038/s41380-019-0459-4
Hoertel N, Franco S, Wall MM, Oquendo MA, Kerridge BT, Limosin F, et al. Mental disorders and risk of suicide attempt: a national prospective study. Mol Psychiatry. 2015;20:718–26.
pubmed: 25980346
doi: 10.1038/mp.2015.19
Blanco C, Hoertel N, Wall MM, Franco S, Peyre H, Neria Y, et al. Toward understanding sex differences in the prevalence of posttraumatic stress disorder: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2018;79:16m11364.
pubmed: 29659210
doi: 10.4088/JCP.16m11364
Blanco C, Hasin DS, Wall MM, Flórez-Salamanca L, Hoertel N, Wang S, et al. Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiatry. 2016;73:388.
pubmed: 26886046
doi: 10.1001/jamapsychiatry.2015.3229
Grant. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39:37–44.
pubmed: 7587973
doi: 10.1016/0376-8716(95)01134-K
Ruan WJ, Goldstein RB, Chou SP, Smith SM, Saha TD, Pickering RP, et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92:27–36.
pubmed: 17706375
doi: 10.1016/j.drugalcdep.2007.06.001
Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82:816–20.
pubmed: 1585961
pmcid: 1694190
doi: 10.2105/AJPH.82.6.816
Ford ES, Anda RF, Edwards VJ, Perry GS, Zhao G, Li C, et al. Adverse childhood experiences and smoking status in five states. Prev Med. 2011;53:188–93.
pubmed: 21726575
doi: 10.1016/j.ypmed.2011.06.015
Lopez-Quintero C, Cobos JPDL, Hasin DS, Okuda M, Wang S, Grant BF, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115:120–30.
pubmed: 21145178
doi: 10.1016/j.drugalcdep.2010.11.004
Blanco C, Rafful C, Wall MM, Ridenour TA, Wang S, Kendler KS. Towards a comprehensive developmental model of cannabis use disorders. Addiction. 2014;109:284–94.
pubmed: 24261668
doi: 10.1111/add.12382
Blanco C, Wall MM, Hoertel N, Krueger RF, Olfson M. Toward a generalized developmental model of psychopathological liabilities and psychiatric disorders. Psychol Med. 2023;53:3406–15.
pubmed: 35125124
doi: 10.1017/S0033291721005468
NIDA. Why is there comorbidity between substance use disorders and mental illnesses? 2021. https://nida.nih.gov/publications/research-reports/common-comorbidities-substance-use-disorders/why-there-comorbidity-between-substance-use-disorders-mental-illnesses . Accessed 24 Apr 2024.
Morisano D, Bacher I, Audrain-McGovern J, George TP. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry. 2009;54:356–67.
pubmed: 19527556
doi: 10.1177/070674370905400603
Lyons M, Hitsman B, Xian H, Panizzon M, Jerskey B, Santangelo S, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob Res. 2008;10:97–108.
pubmed: 18188750
doi: 10.1080/14622200701705332
Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychol Bull. 2015;141:176–212.
pubmed: 25365764
doi: 10.1037/bul0000003
Goodwin R, Hamilton SP. Cigarette smoking and panic: the role of neuroticism. AJP. 2002;159:1208–13.
doi: 10.1176/appi.ajp.159.7.1208
Swendsen J, Le Moal M. Individual vulnerability to addiction. Ann N. Y Acad Sci. 2011;1216:73–85.
pubmed: 21272012
doi: 10.1111/j.1749-6632.2010.05894.x
Hamieh N, Descatha A, Zins M, Goldberg M, Czernichow S, Hoertel N, et al. Physical exertion at work and addictive behaviors: tobacco, cannabis, alcohol, sugar and fat consumption: longitudinal analyses in the CONSTANCES cohort. Sci Rep. 2022;12:661.
pubmed: 35027592
pmcid: 8758679
doi: 10.1038/s41598-021-04475-2
Airagnes G, Lemogne C, Meneton P, Plessz M, Goldberg M, Hoertel N, et al. Alcohol, tobacco and cannabis use are associated with job loss at follow-up: findings from the CONSTANCES cohort. PLoS ONE. 2019;14:e0222361.
pubmed: 31498849
pmcid: 6733456
doi: 10.1371/journal.pone.0222361
Airagnes G, Lemogne C, Goldberg M, Hoertel N, Roquelaure Y, Limosin F, et al. Job exposure to the public in relation with alcohol, tobacco and cannabis use: findings from the CONSTANCES cohort study. PLoS ONE. 2018;13:e0196330.
pubmed: 29715268
pmcid: 5929509
doi: 10.1371/journal.pone.0196330
Matta J, Hoertel N, Airagnes G, Wiernik E, Limosin F, Goldberg M, et al. Does substance use explain social differences in terms of depression? Findings from the Constances cohort. Compr Psychiatry. 2020;102:152203.
pubmed: 32927368
doi: 10.1016/j.comppsych.2020.152203
Ware J, Kosinski M, Turner-Bowker D, Gandek B. SF-12 v2: how to score version 2 of the SF-12 health survey. Boston, MA: The Health Institute, New England Medical Center; 2002. p. 29–38.
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.
doi: 10.1093/biomet/70.1.41
Hill KG, Hawkins JD, Catalano RF, Abbott RD, Guo J. Family influences on the risk of daily smoking initiation. J Adolesc Health. 2005;37:202–10.
pubmed: 16109339
doi: 10.1016/j.jadohealth.2004.08.014
Brook D, Brook J, Zhang C, Whiteman M, Cohen P, Finch S. Developmental trajectories of cigarette smoking from adolescence to the early thirties: Personality and behavioral risk factors. Nicotine Tob Res. 2008;10:1283–91.
pubmed: 18686175
doi: 10.1080/14622200802238993
Pust S, Mohnen SM, Schneider S. Individual and social environment influences on smoking in children and adolescents. Public Health. 2008;122:1324–30.
pubmed: 18804250
doi: 10.1016/j.puhe.2007.12.011
Vander Weg MW. Adverse childhood experiences and cigarette smoking: the 2009 Arkansas and Louisiana behavioral risk factor surveillance systems. Nicotine Tob Res. 2011;13:616–22.
doi: 10.1093/ntr/ntr023
Bos J, Hayden MJ, Lum JAG, Staiger PK. UPPS-P impulsive personality traits and adolescent cigarette smoking: a meta-analysis. Drug Alcohol Depend. 2019;197:335–43.
pubmed: 30878884
doi: 10.1016/j.drugalcdep.2019.01.018
Zhang Z, Kim HJ, Lonjon G, Zhu Y. Balance diagnostics after propensity score matching. Ann Transl Med. 2019;7:16.
pubmed: 30788363
pmcid: 6351359
doi: 10.21037/atm.2018.12.10
Mouelhi Y, Jouve E, Castelli C, Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcomes. 2020;18:136.
pubmed: 32398083
pmcid: 7218583
doi: 10.1186/s12955-020-01344-w
Lumley T ‘survey: analysis of complex survey samples’ R package version 4. 2024.
Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. IJERPH. 2010;7:3760–91.
pubmed: 21139859
pmcid: 2996190
doi: 10.3390/ijerph7103760
Conti AA, McLean L, Tolomeo S, Steele JD, Baldacchino A. Chronic tobacco smoking and neuropsychological impairments: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;96:143–54.
pubmed: 30502351
doi: 10.1016/j.neubiorev.2018.11.017
Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav. 2013;3:302–26.
pubmed: 23785661
pmcid: 3683289
doi: 10.1002/brb3.137
Weinberger AH, Funk AP, Goodwin RD. A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders. Prev Med. 2016;92:148–59.
pubmed: 27196143
pmcid: 5085842
doi: 10.1016/j.ypmed.2016.05.011
Verplaetse TL, McKee SA. An overview of alcohol and tobacco/nicotine interactions in the human laboratory. Am J Drug Alcohol Abus. 2017;43:186–96.
doi: 10.1080/00952990.2016.1189927
Leventhal AM, Ameringer KJ, Osborn E, Zvolensky MJ, Langdon KJ. Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug Alcohol Depend. 2013;133:324–9.
pubmed: 23896304
pmcid: 4049140
doi: 10.1016/j.drugalcdep.2013.06.015
Taylor GM, Lindson N, Farley A, Leinberger-Jabari A, Sawyer K, Te Water Naudé R, et al. Smoking cessation for improving mental health. Cochrane Database Syst Rev. 2021;3:CD013522.
Cavazos-Rehg PA, Breslau N, Hatsukami D, Krauss MJ, Spitznagel EL, Grucza RA, et al. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med. 2014;44:2523–35.
pubmed: 25055171
pmcid: 4122254
doi: 10.1017/S0033291713003206
Barkhuizen W, Dudbridge F, Ronald A. Genetic overlap and causal associations between smoking behaviours and mental health. Sci Rep. 2021;11:14871.
pubmed: 34290290
pmcid: 8295327
doi: 10.1038/s41598-021-93962-7
Tsuang MT, Francis T, Minor K, Thomas A, Stone WS. Genetics of smoking and depression. Hum Genet. 2012;131:905–15.
pubmed: 22526528
doi: 10.1007/s00439-012-1170-6
Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010;196:440–6.
pubmed: 20513853
doi: 10.1192/bjp.bp.109.065912
Adjibade M, Lemogne C, Julia C, Hercberg S, Galan P, Assmann KE, et al. Prospective association between combined healthy lifestyles and risk of depressive symptoms in the French NutriNet-Santé cohort. J Affect Disord. 2018;238:554–62.
pubmed: 29940519
doi: 10.1016/j.jad.2018.05.038
Yao Y, Xu Y, Cai Z, Liu Q, Ma Y, Li AN, et al. Determination of shared genetic etiology and possible causal relations between tobacco smoking and depression. Psychol Med. 2021;51:1870–9.
pubmed: 32249730
doi: 10.1017/S003329172000063X
Treur JL, Munafò MR, Logtenberg E, Wiers RW, Verweij KJH. Using Mendelian randomization analysis to better understand the relationship between mental health and substance use: a systematic review. Psychol Med. 2021;51:1593–624.
pubmed: 34030749
pmcid: 8327626
doi: 10.1017/S003329172100180X
Amiri S. The prevalence of depression symptoms after smoking cessation: a systematic review and meta-analysis. J Addict Dis. 2020;39:109–24.
pubmed: 33084511
doi: 10.1080/10550887.2020.1826104
Vermeulen JM, Wootton RE, Treur JL, Sallis HM, Jones HJ, Zammit S, et al. Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study. Br J Psychiatry. 2021;218:88–94.
pubmed: 31526406
doi: 10.1192/bjp.2019.202
Schramm E, Klein DN, Elsaesser M, Furukawa TA, Domschke K. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry. 2020;7:801–12.
pubmed: 32828168
doi: 10.1016/S2215-0366(20)30099-7
Le Strat Y, Hoertel N. Correlation is no causation: gymnasium proliferation and the risk of obesity. Addiction. 2011;106:1871–2.
pubmed: 21917042
doi: 10.1111/j.1360-0443.2011.03547.x
Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health. 1992;82:33–36.
pubmed: 1536331
pmcid: 1694439
doi: 10.2105/AJPH.82.1.33
Folpmers S, Mook-Kanamori DO, De Mutsert R, Rosendaal FR, Willems Van Dijk K, Van Heemst D, et al. Agreement between nicotine metabolites in blood and self-reported smoking status: The Netherlands Epidemiology of Obesity study. Addict Behav Rep. 2022;16:100457.
pubmed: 36187563
pmcid: 9519471
Vartiainen E. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health. 2002;56:167–70.
pubmed: 11854334
pmcid: 1732104
doi: 10.1136/jech.56.3.167
Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 2014;311:172.
pubmed: 24399556
pmcid: 5555156
doi: 10.1001/jama.2013.284985
Han B, Volkow ND, Blanco C, Tipperman D, Einstein EB, Compton WM. Trends in prevalence of cigarette smoking among US adults with major depression or substance use disorders, 2006-2019. JAMA. 2022;327:1566.
pubmed: 35471512
pmcid: 9044114
doi: 10.1001/jama.2022.4790
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3:A42.
pubmed: 16539783
pmcid: 1563985